Skip Navigation

FTC sues drug middlemen for allegedly inflating insulin prices

www.cnbc.com FTC sues drug middlemen for allegedly inflating insulin prices

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.

FTC sues drug middlemen for allegedly inflating insulin prices
  • The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while "artificially" inflating costs for patients.
  • The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts, and their affiliated group purchasing organizations.
  • The FTC may also recommend suing insulin manufacturers Eli Lilly, Sanofi and Novo Nordisk in the future.
17

You're viewing a single thread.

17 comments
17 comments